Manufacturing Source Sample Clauses

Manufacturing Source. The Borrowers shall establish a manufacturing source based in the United States (or such other location as is mutually agreed to by the Purchaser and the Borrowers), which source shall, within one hundred eighty (180) days following the Closing Date, deliver both a working senior unit and a working junior unit (in each instance, a prototype or a first article unit) to the Borrowers. The Borrowers shall, within two hundred seventy (270) days following the Closing Date, terminate all contracts, agreements and other arrangements with the Israeli manufacturing source.
Sample 1Sample 2
AutoNDA by SimpleDocs
Manufacturing Source. To the extent that upon the completion of Phase II of the Research Program Paravax owns, or leases pursuant to a long term lease, a manufacturing facility which has been approved by the United States Department of Agriculture or, if applicable, the United States Food and Drug Administration which allows Paravax to produce Toxoplasmosis Vaccine for which regulatory approval or clearance for sale can be obtained in a specific country in the Territory, the parties shall proceed as though Paravax shall manufacture the Toxoplasmosis Vaccine for distribution in that country by Bayer pursuant to the Distribution Agreement. To the extent that upon the completion of Phase II of the Research Program Paravax does not have such an approved manufacturing facility which allows it to produce Toxoplasmosis Vaccine for which regulatory approval or clearance for sale can be obtained in a specific country, the parties shall proceed as though Bayer shall manufacture the Toxoplasmosis Vaccine for distribution in that country by Bayer pursuant to the Distribution Agreement. Paravax may elect to forego or cease manufacture of Toxoplasmosis Vaccine at any time, provided that Paravax gives Bayer adequate notice to allow Bayer, or a third party, to prepare for the manufacturing requirements of producing the Toxoplasmosis Vaccine for, as applicable, Phases III and IV of the Research Program and/or manufacture for commercial sale. After the commencement of Phase III of the Research Program, Paravax shall have no right to regain from Bayer the right to manufacture the Toxoplasmosis Vaccine; however, Bayer agrees that it shall favorably consider any such request made by Paravax. In the event that Paravax elects to forego or cease manufacture of the Toxoplasmosis Vaccine, Bayer shall be entitled to manufacture all of Bayer's requirements for Toxoplasmosis Vaccine pursuant to the license described in Section 5.3 above.
Sample 1
Manufacturing Source. Notwithstanding anything contained in this Section 12.5, NaPro shall not have any obligation to provide to a Stand-By Manufacturing Source Confidential Information or technical support for the semi-synthetic manufacture of Bulk Drug. 12.6
Sample 1
Manufacturing Source. The Product will be manufactured by Manufacturer at its site located in Industria Vidriera 80, Xxxxx. Xxxxxxxxxx Xxxxxxx Xxxxx, 00000, Xxxxxxx, Xxxxxxx, Xxxxxx, or another site proposed by Manufacturer that Licensee has been notified about in advance in writing by Manufacturer, and that has been expressly accepted by Licensee acceptance that shall not be unreasonably withheld, conditioned or delayed, provided such transfer does not result in a Supply Disruption. Any of the alternative sites proposed by Manufacturer shall comply with any applicable law. Manufacturer shall have the obligation at all times during the Term of this Agreement to obtain and maintain the government authorizations, permits, approvals and/or licenses required to enable Manufacturer to manufacture and, as the case may be, to import the Product as well as any and all raw materials and components used for the manufacture of the Products in the Territory and to provide such Product for shipment to Licensee to the location specified in Section 3.3 of this Agreement, in the understanding that Manufacturer shall assume and disburse all costs and fees associated with obtaining or maintenance of such government authorizations, permits, approvals and/or licenses.
Sample 1
Manufacturing Source. The Borrowers shall establish a manufacturing source based in the United States (or such other location as is mutually agreed to by the Purchaser and the Borrowers), which source shall, within one hundred and fifty (150) days following the Amendment No. 1 Waiver/Amendment Effective Date, deliver both a working senior unit and a working junior unit (in each instance, a prototype or a first article unit) to the Borrowers.”
Sample 1
Manufacturing Source. As partial consideration for the grant of the License, Racom hereby commits to engage Rohm as its primary manufacturing source for ferroelectric RFID products. Rohm shall have the first opportunity to supply Racom's needs for ferroelectric RFID products worldwide including both direct purchases by Racom from Rohm and indirect purchases made through Ramtron. As partial consideration for the grant of the License, Rohm commits to use its best efforts to supply Racom's ferroelectric RFID product manufacturing needs under most favorable commercial terms and with competitive quality, delivery and pricing. In addition to the rights granted in Section 2.1 above, during the term of this Agreement, Racom hereby grants to Rohm a royalty-free, non- exclusive, non-sublicensable, non-transferable right and license to use the Ferroelectric RFID Technology for the sole purpose of manufacturing for, and sale of ferroelectric RFID products exclusively to Racom.
Sample 1
Manufacturing Source. The Product will be manufactured by Manufacturer at its site located in Industria Vidriera 80, Xxxxx. Xxxxxxxxxx Xxxxxxx Xxxxx, 00000, Xxxxxxx, Xxxxxxx, Xxxxxx, or another site proposed by Manufacturer that More Pharma has been notified about in advance in writing by Manufacturer, and that has been expressly accepted by More Pharma acceptance that shall not be unreasonably withheld, conditioned or delayed, provided such transfer does not result in a Supply Disruption. Any of the alternative sites proposed by Manufacturer shall comply with any applicable law. Manufacturer will provide such Product for shipment to More Pharma to the location specified in Section 3.2 of this Agreement.
Sample 1
AutoNDA by SimpleDocs
Manufacturing Source. Licensee represents that the Licensed Products will be manufactured for Licensee by a person or entity who agrees to be bound by the terms hereof, and each shall sign the attached Schedule C prior to the manufacture of the Licensed Products pursuant to this Agreement. Equilink agrees during the Term not to disclose the name of such manufacturers (unless such names become known to the public other than by disclosure by Licensor) or contact such manufacturers other than through Licensee in connection with this Agreement.
Sample 1

Related to Manufacturing Source

  • Manufacturing Services Jabil will manufacture the Product in accordance with the Specifications and any applicable Build Schedules. Jabil will reply to each proposed Build Schedule that is submitted in accordance with the terms of this Agreement by notifying Company of its acceptance or rejection within three (3) business days of receipt of any proposed Build Schedule. In the event of Jabil’s rejection of a proposed Build Schedule, Jabil’s notice of rejection will specify the basis for such rejection. When requested by Company, and subject to appropriate fee and cost adjustments, Jabil will provide Additional Services for existing or future Product manufactured by Jabil. Company shall be solely responsible for the sufficiency and adequacy of the Specifications [***].

  • Joint Manufacturing Committee A joint manufacturing committee (the “Joint Manufacturing Committee” or “JMC”) will be established pursuant to the Supply Agreement. The roles and responsibilities of the JMC shall be as specified in the Supply Agreement.

  • Manufacture of Product Prior to commercialization of the Product, the Parties may, if appropriate for both parties, negotiate in good faith a manufacturing and supply agreement to provide for Licensor to fulfill the manufacturing requirements of Licensee for Product for sale in the European market. The cost of such manufacturing shall not be greater than * percent (*%) of the cost of any competitor cGMP contract manufacturing facility that proposes to manufacturer the Product for Licensee. * Confidential information has been omitted and filed confidentially with the Securities and Exchange Commission.

  • Manufacturing License Subject to the terms of this Agreement, including without limitation Section 2.2, Theravance grants to GSK an exclusive license under the Theravance Patents and Theravance Know-How to make and have made API Compound or formulated Alliance Product in the Territory.

  • Manufacture of Products All Products marketed through Grantor's Web ------------------------- Site shall be manufactured, packaged, prepared, and shipped in accordance with the specifications and requirements described on Exhibit A hereto as it may be modified from time to time. Quality control standards relating to the Product's weight, color, consistency, micro-biological content, labeling and packaging are also set forth on Exhibit A. In the event that Exhibit A is incomplete, Products shall be manufactured and shipped in accordance with industry standards.

  • API A. Reliant shall supply to Cardinal Health for Manufacturing and Packaging, at Reliant’s sole cost, the API and applicable reference standards in quantities sufficient to meet Reliant’s requirements for each Product as further set forth in Article 4. Prior to delivery of any of the API or reference standard to Cardinal Health for Manufacturing and Packaging, Reliant shall provide to Cardinal Health a copy of the API Material Safety Data Sheet (“MSDS”), as amended, and any subsequent revisions thereto. Reliant shall supply the API, reference standards, and Certificate of Analysis FOB the Facility no later than thirty (30) days before the scheduled Manufacture Date upon which such API will be used by Cardinal Health. Upon receipt of the API, Cardinal Health shall conduct identification testing of the API. Cardinal Health shall use the API solely and exclusively for Manufacturing and Packaging under this Agreement. The maximum volume of API that Reliant supplies to Cardinal Health shall not exceed the amount reflected in the Firm Commitment and the next six (6) months of the Rolling Forecast.

  • Product The term “

  • Manufacturing Intrexon shall have the option and, in the event it so elects, shall use Diligent Efforts, to perform any manufacturing activities in connection with the Aquaculture Program that relate to the Intrexon Materials, including through the use of a suitable Third Party contract manufacturer. To the extent that Intrexon so elects, Intrexon may request that AquaBounty and Intrexon establish and execute a separate manufacturing and supply agreement, which agreement will establish and govern the production, quality assurance, and regulatory activities associated with manufacture of Intrexon Materials. Except as provided in Section 4.1, any manufacturing undertaken by Intrexon pursuant to the preceding sentence shall be performed in exchange for cash payments equal to Intrexon’s Fully Loaded Cost in connection with such manufacturing, on terms to be negotiated by the Parties in good faith. In the event that Intrexon does not manufacture Intrexon Materials or bulk quantities of other components of AquaBounty Products, then Intrexon shall provide to AquaBounty or a contract manufacturer selected by AquaBounty and approved by Intrexon (such approval not to be unreasonably withheld) all Information Controlled by Intrexon that is (a) related to the manufacturing of such Intrexon Materials or bulk qualities of other components of AquaBounty Products for use in the Field and (b) reasonably necessary to enable AquaBounty or such contract manufacturer (as appropriate) for the sole purpose of manufacturing such Intrexon Materials or bulk quantities of other components of AquaBounty Products. The costs and expenses incurred by Intrexon in carrying out such transfer shall be borne by Intrexon. Any manufacturing Information transferred hereunder to AquaBounty or its contract manufacturer shall not be further transferred to any Third Party, including any Product Sublicensee, or any AquaBounty Affiliate without the prior written consent of Intrexon; provided, however, that Intrexon shall not unreasonably withhold such consent if necessary to permit AquaBounty to switch manufacturers.

  • Manufacturing Costs In the event of termination by Merck pursuant to Section 6.2, 6.3 or 6.6 above, Merck shall be entitled to [*****] (as defined herein) incurred by Merck for its Compound Delivered for the Study. [*****]

  • New Products You agree to comply with NASD Notice to Members 5-26 recommending best practices for reviewing new products.

Time is Money Join Law Insider Premium to draft better contracts faster.